{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:28:15Z","timestamp":1774531695299,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000836","name":"University of Liverpool","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013175","name":"European Society for Clinical Investigation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jinf.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T12:34:54Z","timestamp":1524573294000},"page":"515-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV\/HBV positive adults in Ghana"],"prefix":"10.1016","volume":"76","author":[{"given":"G.","family":"Villa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.O.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5639-0528","authenticated-orcid":false,"given":"A.","family":"Beloukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.T.","family":"Appiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-9610","authenticated-orcid":false,"given":"D.","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-5093","authenticated-orcid":false,"given":"F.S.","family":"Sarfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-1612","authenticated-orcid":false,"given":"F.","family":"Post","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AM","family":"Geretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2018.03.001_bib0001","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/QAD.0000000000001572","article-title":"Tenofovir-induced toxicity in renal proximal tubular epithelial cells: involvement of mitochondria","volume":"31","author":"Mili\u00e1n","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0003","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/QAD.0000000000001464","article-title":"Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals","volume":"31","author":"Ryom","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0004","unstructured":"Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents 2017. Available at: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf (Accessed 11\/03\/2018)."},{"key":"10.1016\/j.jinf.2018.03.001_bib0005","unstructured":"European AIDS Clinical Society. Guidelines version 9.0 October 2017. Available at: http:\/\/www.eacsociety.org\/files\/guidelines_8.2-english.pdf (last access 10\/03\/2018)."},{"key":"10.1016\/j.jinf.2018.03.001_bib0006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/infdis\/jiu107","article-title":"Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure","volume":"210","author":"Jose","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0007","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/QAD.0000000000000202","article-title":"Renal events among women treated with tenofovir\/emtricitabine in combination with either lopinavir\/ritonavir or nevirapine","volume":"28","author":"Mwafongo","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0008","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/15284336.2016.1243363","article-title":"Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection","volume":"17","author":"Bedimo","year":"2016","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jinf.2018.03.001_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7448\/IAS.20.01\/21317","article-title":"Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: A retrospective cohort study","volume":"20","author":"De Waal","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jinf.2018.03.001_bib0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jinf.2017.01.010","article-title":"Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate","volume":"74","author":"Hamzah","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2018.03.001_bib0011","unstructured":"World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, June 2016. Available at: www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/ (last access 06\/03\/2018)."},{"key":"10.1016\/j.jinf.2018.03.001_bib0012","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1310\/hct1506-246","article-title":"Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: A focused safety analysis of ACTG PEARLS (A5175)","volume":"15","author":"Touzard Romo","year":"2014","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jinf.2018.03.001_bib0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12981-016-0113-z","article-title":"The effect of tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis","volume":"13","author":"Salome","year":"2016","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.jinf.2018.03.001_bib0014","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/S2352-3018(16)00016-3","article-title":"The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: A mathematical modelling study","volume":"3","author":"Estill","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jinf.2018.03.001_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcv.2014.05.018","article-title":"Epidemiology and impact of HIV coinfection with Hepatitis B and Hepatitis C viruses in sub-Saharan Africa","volume":"61","author":"Matthews","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jinf.2018.03.001_bib0016","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/cid\/ciu734","article-title":"Chronic hepatitis B virus coinfection is associated with renal impairment among Zambian HIV-infected adults","volume":"59","author":"Mweemba","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0017","doi-asserted-by":"crossref","first-page":"e40245","DOI":"10.1371\/journal.pone.0040245","article-title":"Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults","volume":"7","author":"Mocroft","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.03.001_bib0018","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/JCM.02231-09","article-title":"Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana","volume":"48","author":"Geretti","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2018.03.001_bib0019","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/civ421","article-title":"Liver fibrosis by transient elastography and virologic outcomes after introduction of tenofovir in lamivudine-experienced adults with HIV and Hepatitis B Virus coinfection in Ghana","volume":"61","author":"Stockdale","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2893.2010.01275.x","article-title":"Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV\/HBV-coinfected patients","volume":"18","author":"Miailhes","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jinf.2018.03.001_bib0021","unstructured":"US Department of Health and Human Services. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, Version 2.1, March 2017. Available from: https:\/\/rsc.tech-res.com\/docs\/default-source\/safety\/daids-ae-grading-table-mar2017.pdf (last accessed 09\/09\/2017)."},{"key":"10.1016\/j.jinf.2018.03.001_bib0022","doi-asserted-by":"crossref","first-page":"e2008","DOI":"10.1371\/journal.pntd.0002008","article-title":"The urine circulating cathodic antigen (CCA) dipstick: A valid substitute for microscopy for mapping and point-of-care diagnosis of intestinal schistosomiasis","volume":"7","author":"Sousa-Figueiredo","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-13-85","article-title":"Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients","volume":"13","author":"Campbell","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jinf.2018.03.001_bib0024","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/HJH.0000000000000924","article-title":"Chronic kidney disease epidemiology collaboration-derived glomerular filtration rate performs better at detecting preclinical end-organ changes than alternative equations in black Africans","volume":"34","author":"Booysen","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.jinf.2018.03.001_bib0025","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: A pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0026","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/QAD.0b013e32835fac51","article-title":"Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate >\/= 60\u00a0ml\/min per 1.73\u00a0m2","volume":"27","author":"Reynes","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0027","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.2011.124","article-title":"Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy","volume":"80","author":"Dauchy","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.jinf.2018.03.001_bib0028","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0029","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990\u20132015","volume":"317","author":"Forouzanfar","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2018.03.001_bib0030","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/S2214-109X(14)70002-6","article-title":"The epidemiology of chronic kidney disease in sub-Saharan Africa: A systematic review and meta-analysis","volume":"2","author":"Stanifer","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jinf.2018.03.001_bib0031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5414\/CNP86S128","article-title":"The challenges of ESRD care in developing economies: sub-Saharan African opportunities for significant improvement","volume":"86","author":"Bamgboye","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jinf.2018.03.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136529","article-title":"Albuminuria is associated with traditional cardiovascular risk factors and viral load in HIV-infected patients in rural South Africa","volume":"10","author":"Wensink","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2018.03.001_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/QAI.0000000000001302","article-title":"Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications","volume":"75","author":"Sheets","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2018.03.001_bib0034","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QAD.0000000000000901","article-title":"Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir","volume":"30","author":"Casado","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0035","doi-asserted-by":"crossref","first-page":"58","DOI":"10.33590\/emj\/10312319","article-title":"The role of gender in chronic kidney disease","volume":"1","author":"Goldberg","year":"2016","journal-title":"Eur Med J"},{"key":"10.1016\/j.jinf.2018.03.001_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000125","article-title":"Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: A systematic review","volume":"1","author":"Heestermans","year":"2016","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.jinf.2018.03.001_bib0037","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/gfp765","article-title":"Assessment of GFR by four methods in adults in Ashanti, Ghana: the need for an eGFR equation for lean African populations","volume":"25","author":"Eastwood","year":"2010","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.jinf.2018.03.001_bib0038","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/655681","article-title":"Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients","volume":"51","author":"Cooper","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0039","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0000000000000103","article-title":"Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity","volume":"28","author":"Yombi","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/QAD.0000000000001353","article-title":"Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir","volume":"31","author":"Jose","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2018.03.001_bib0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5527\/wjn.v4.i2.295","article-title":"African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era","volume":"6","author":"Kasembeli","year":"2015","journal-title":"World J Nephrol"},{"key":"10.1016\/j.jinf.2018.03.001_bib0042","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/QAI.0000000000000259","article-title":"HIV-associated renal and genitourinary comorbidities in Africa","volume":"67","author":"Kalyesubula","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2018.03.001_bib0043","doi-asserted-by":"crossref","first-page":"48","DOI":"10.9735\/0975-3702.3.2.48-52","article-title":"Prevalence of Schistosoma haematobium infection in Ghana: A retrospective case study in Kumasi","volume":"3","author":"Tay","year":"2011","journal-title":"Int J Parasitol Res"},{"key":"10.1016\/j.jinf.2018.03.001_bib0044","doi-asserted-by":"crossref","first-page":"e1200","DOI":"10.1371\/journal.pntd.0001200","article-title":"Mapping helminth co-infection and co-intensity: Geostatistical prediction in Ghana","volume":"5","author":"Soares Magalh\u00e3es","year":"2011","journal-title":"PLoS Neglect Trop Dis"},{"key":"10.1016\/j.jinf.2018.03.001_bib0045","doi-asserted-by":"crossref","first-page":"e1151","DOI":"10.1371\/journal.pone.0115197","article-title":"Renal function in hepatosplenic Schistosomiasis \u2013 An assessment of renal tubular disorders","volume":"9","author":"Duarte","year":"2014","journal-title":"PLoS One"},{"issue":"4 Suppl 3","key":"10.1016\/j.jinf.2018.03.001_bib0046","doi-asserted-by":"crossref","first-page":"19583","DOI":"10.7448\/IAS.17.4.19583","article-title":"Should the dose of tenofovir be reduced to 200\u2013250\u00a0mg\/day, when combined with protease inhibitors?","volume":"17","author":"Hill","year":"2014","journal-title":"J Int AIDS Soc"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318300847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445318300847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:25:40Z","timestamp":1759008340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445318300847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0163445318300847"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2018.03.001","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV\/HBV positive adults in Ghana","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}